Skip to main content
Top
Published in: Inflammation 2/2014

Open Access 01-04-2014

Increased Concentration of C-Reactive Protein in Obese Patients with Type 2 Diabetes Is Associated with Obesity and Presence of Diabetes but Not with Macrovascular and Microvascular Complications or Glycemic Control

Authors: Aneta Fronczyk, Piotr Molęda, Krzysztof Safranow, Wiesław Piechota, Lilianna Majkowska

Published in: Inflammation | Issue 2/2014

Login to get access

Abstract

The purpose of this study was to assess the concentration of C-reactive protein (CRP) in obese type 2 diabetes mellitus (DM2) patients and its association with macrovascular and microvascular complications. The study group consisted of 80 obese DM2 patients, including 20 macrovascular, 20 microvascular, 20 both macrovascular and microvascular, and 20 with no complications patients. The control group comprised 40 normoglycemic subjects—20 obese and 20 of normal body weight. Highly sensitive CRP and metabolic control parameters were assessed. CRP levels in obese diabetes subgroups and normoglycemic obese were similar and significantly higher than those in nonobese controls. No correlation was found between CRP and diabetes control parameters. There was a strong positive correlation between CRP level and body mass index in all groups. A multivariate analysis showed that DM2 and obesity are independent factors increasing CRP levels. Increased concentration of CRP in obese DM2 patients is related to obesity and diabetes itself. The lack of association between CRP and vascular complications remains unclear.
Literature
1.
go back to reference Bray, G.A., M.B. Clearfield, D.J. Fintel, and D.S. Nelinson. 2009. Overweight and obesity: The pathogenesis of cardiometabolic risk. Clinical Cornerstone 9(4): 30–40. discussion 41–42.PubMedCrossRef Bray, G.A., M.B. Clearfield, D.J. Fintel, and D.S. Nelinson. 2009. Overweight and obesity: The pathogenesis of cardiometabolic risk. Clinical Cornerstone 9(4): 30–40. discussion 41–42.PubMedCrossRef
2.
go back to reference Garcia, C., B. Feve, P. Ferré, et al. 2010. Diabetes and inflammation: Fundamental aspects and clinical implications. Diabetes & Metabolism 36(5): 327–338.CrossRef Garcia, C., B. Feve, P. Ferré, et al. 2010. Diabetes and inflammation: Fundamental aspects and clinical implications. Diabetes & Metabolism 36(5): 327–338.CrossRef
4.
go back to reference Yosef-Levi, I.M., E. Grad, and H.D. Danenberg. 2007. C-reactive protein and atherothrombosis—a prognostic factor or a risk factor? Harefuah 146(12): 970–974.PubMed Yosef-Levi, I.M., E. Grad, and H.D. Danenberg. 2007. C-reactive protein and atherothrombosis—a prognostic factor or a risk factor? Harefuah 146(12): 970–974.PubMed
5.
go back to reference Kahn, S.E., B. Zinman, S.M. Haffner, et al. 2006. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes 55(8): 2357–2364.PubMedCrossRef Kahn, S.E., B. Zinman, S.M. Haffner, et al. 2006. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes 55(8): 2357–2364.PubMedCrossRef
6.
go back to reference Park, J.S., M.H. Cho, J.S. Nam, et al. 2010. Visceral adiposity and leptin are independently associated with C-reactive protein in Korean type 2 diabetic patients. Acta Diabetologica 47(2): 113–118.PubMedCrossRef Park, J.S., M.H. Cho, J.S. Nam, et al. 2010. Visceral adiposity and leptin are independently associated with C-reactive protein in Korean type 2 diabetic patients. Acta Diabetologica 47(2): 113–118.PubMedCrossRef
7.
go back to reference Belfki, H., S. Ben Ali, S. Bougatef, et al. 2012. Association between C-reactive protein and type 2 diabetes in a Tunisian population. Inflammation 35(2): 684–689.PubMedCrossRef Belfki, H., S. Ben Ali, S. Bougatef, et al. 2012. Association between C-reactive protein and type 2 diabetes in a Tunisian population. Inflammation 35(2): 684–689.PubMedCrossRef
8.
go back to reference Mahajan, A., R. Tabassum, S. Chavali, et al. 2009. High-sensitivity C-reactive protein levels and type 2 diabetes in urban North Indians. Journal of Clinical Endocrinology and Metabolism 94(6): 2123–2127.PubMedCrossRef Mahajan, A., R. Tabassum, S. Chavali, et al. 2009. High-sensitivity C-reactive protein levels and type 2 diabetes in urban North Indians. Journal of Clinical Endocrinology and Metabolism 94(6): 2123–2127.PubMedCrossRef
9.
go back to reference Lu, B., Y. Yang, Z. Yang, et al. 2010. Insulin resistance in Chinese patients with type 2 diabetes is associated with C-reactive protein independent of abdominal obesity. Cardiovascular Diabetology 9: 92.PubMedCentralPubMedCrossRef Lu, B., Y. Yang, Z. Yang, et al. 2010. Insulin resistance in Chinese patients with type 2 diabetes is associated with C-reactive protein independent of abdominal obesity. Cardiovascular Diabetology 9: 92.PubMedCentralPubMedCrossRef
10.
go back to reference Kanai, A., T. Kawamura, T. Umemura, et al. 2008. Association between future events of brain infarction and soluble levels of intercellular adhesion molecule-1 and C-reactive protein in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 82(2): 157–164.PubMedCrossRef Kanai, A., T. Kawamura, T. Umemura, et al. 2008. Association between future events of brain infarction and soluble levels of intercellular adhesion molecule-1 and C-reactive protein in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 82(2): 157–164.PubMedCrossRef
11.
go back to reference Pu, L.J., L. Lu, X.W. Xu, et al. 2006. Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes. Cardiovascular Diabetology 5: 27.PubMedCentralPubMedCrossRef Pu, L.J., L. Lu, X.W. Xu, et al. 2006. Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes. Cardiovascular Diabetology 5: 27.PubMedCentralPubMedCrossRef
12.
go back to reference Cox, A.J., S. Agarwal, D. M Herrington, J.J. Carr, B.I. Freedman, and D.W. Bowden. 2012. C-reactive protein concentration predicts mortality in type 2 diabetes: The Diabetes Heart Study. Diabetic Medicine 29(6): 767–770.PubMedCrossRef Cox, A.J., S. Agarwal, D. M Herrington, J.J. Carr, B.I. Freedman, and D.W. Bowden. 2012. C-reactive protein concentration predicts mortality in type 2 diabetes: The Diabetes Heart Study. Diabetic Medicine 29(6): 767–770.PubMedCrossRef
13.
go back to reference Su, G., S. Mi, H. Tao, et al. 2011. Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes. Cardiovascular Diabetology 10: 19.PubMedCentralPubMedCrossRef Su, G., S. Mi, H. Tao, et al. 2011. Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes. Cardiovascular Diabetology 10: 19.PubMedCentralPubMedCrossRef
14.
go back to reference Jin, C., L. Lu, R.Y. Zhang, et al. 2009. Association of serum glycated albumin, C-reactive protein and ICAM-1 levels with diffuse coronary artery disease in patients with type 2 diabetes mellitus. Clinica Chimica Acta 408(1–2): 45–49.CrossRef Jin, C., L. Lu, R.Y. Zhang, et al. 2009. Association of serum glycated albumin, C-reactive protein and ICAM-1 levels with diffuse coronary artery disease in patients with type 2 diabetes mellitus. Clinica Chimica Acta 408(1–2): 45–49.CrossRef
15.
go back to reference Lau, D.C., B. Dhillon, H. Yan, P.E. Szmitko, and S. Verma. 2005. Adipokines: Molecular links between obesity and atherosclerosis. American Journal of Physiology. Heart and Circulatory Physiology 288(5): 2031–2041.CrossRef Lau, D.C., B. Dhillon, H. Yan, P.E. Szmitko, and S. Verma. 2005. Adipokines: Molecular links between obesity and atherosclerosis. American Journal of Physiology. Heart and Circulatory Physiology 288(5): 2031–2041.CrossRef
16.
go back to reference Pasceri, V., J.T. Willerson, and E.T. Yeh. 2000. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102(18): 2165–2168.PubMedCrossRef Pasceri, V., J.T. Willerson, and E.T. Yeh. 2000. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102(18): 2165–2168.PubMedCrossRef
17.
go back to reference Abrahamian, H., G. Endler, M. Exner, et al. 2007. Association of low-grade inflammation with nephropathy in type 2 diabetic patients: Role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines. Experimental and Clinical Endocrinology and Diabetes 115(1): 38–41.PubMedCrossRef Abrahamian, H., G. Endler, M. Exner, et al. 2007. Association of low-grade inflammation with nephropathy in type 2 diabetic patients: Role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines. Experimental and Clinical Endocrinology and Diabetes 115(1): 38–41.PubMedCrossRef
18.
go back to reference Festa, A., R. D'Agostino, G. Howard, L. Mykkänen, R.P. Tracy, and S.M. Haffner. 2000. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney International 58(4): 1703–1710.PubMedCrossRef Festa, A., R. D'Agostino, G. Howard, L. Mykkänen, R.P. Tracy, and S.M. Haffner. 2000. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney International 58(4): 1703–1710.PubMedCrossRef
19.
go back to reference Navarro, J.F., C. Mora, M. Maca, and J. Garca. 2003. Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. American Journal of Kidney Diseases 42(1): 53–61.PubMedCrossRef Navarro, J.F., C. Mora, M. Maca, and J. Garca. 2003. Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. American Journal of Kidney Diseases 42(1): 53–61.PubMedCrossRef
20.
go back to reference Del Cañizo Gómez, F.J., C. Fernández Pérez, I. Moreno Ruiz, et al. 2011. Microvascular complications and the risk factors in patients with type 2 diabetes. Endocrinología y Nutrición 58(4): 163–168.PubMedCrossRef Del Cañizo Gómez, F.J., C. Fernández Pérez, I. Moreno Ruiz, et al. 2011. Microvascular complications and the risk factors in patients with type 2 diabetes. Endocrinología y Nutrición 58(4): 163–168.PubMedCrossRef
21.
go back to reference Nowak, M., T. Wielkoszyński, B. Marek, et al. 2010. Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy. Clinical and Experimental Medicine 10(3): 185–192.PubMedCrossRef Nowak, M., T. Wielkoszyński, B. Marek, et al. 2010. Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy. Clinical and Experimental Medicine 10(3): 185–192.PubMedCrossRef
22.
go back to reference Anan, F., T. Masaki, Y. Umeno, et al. 2007. Correlations of high-sensitivity C-reactive protein and atherosclerosis in Japanese type 2 diabetes patients. European Journal of Endocrinology 157(3): 311–317.PubMedCrossRef Anan, F., T. Masaki, Y. Umeno, et al. 2007. Correlations of high-sensitivity C-reactive protein and atherosclerosis in Japanese type 2 diabetes patients. European Journal of Endocrinology 157(3): 311–317.PubMedCrossRef
23.
go back to reference Gustavsson, C.G., and C.D. Agardh. 2004. Markers of inflammation in patients with coronary artery disease are also associated with glycosylated haemoglobin A1c within the normal range. European Heart Journal 25(23): 2120–2124.PubMedCrossRef Gustavsson, C.G., and C.D. Agardh. 2004. Markers of inflammation in patients with coronary artery disease are also associated with glycosylated haemoglobin A1c within the normal range. European Heart Journal 25(23): 2120–2124.PubMedCrossRef
24.
go back to reference Huffman, F., S. Whisner, G.G. Zarini, and S. Nath. 2010. Waist circumference and BMI in relation to serum high sensitivity C-reactive protein (hs-CRP) in Cuban Americans with and without type 2 diabetes. International Journal of Environmental Research and Public Health 7(3): 842–852.PubMedCentralPubMedCrossRef Huffman, F., S. Whisner, G.G. Zarini, and S. Nath. 2010. Waist circumference and BMI in relation to serum high sensitivity C-reactive protein (hs-CRP) in Cuban Americans with and without type 2 diabetes. International Journal of Environmental Research and Public Health 7(3): 842–852.PubMedCentralPubMedCrossRef
25.
go back to reference Pfützner, A., E. Standl, H.J. Strotmann, et al. 2006. Association of high-sensitive C-reactive protein with advanced stage beta-cell dysfunction and insulin resistance in patients with type 2 diabetes mellitus. Clinical Chemistry and Laboratory Medicine 44(5): 556–560.PubMedCrossRef Pfützner, A., E. Standl, H.J. Strotmann, et al. 2006. Association of high-sensitive C-reactive protein with advanced stage beta-cell dysfunction and insulin resistance in patients with type 2 diabetes mellitus. Clinical Chemistry and Laboratory Medicine 44(5): 556–560.PubMedCrossRef
26.
go back to reference Streja, D., P. Cressey, and S.W. Rabkin. 2003. Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus. Journal of Diabetes and its Complications 17(3): 120–127.PubMedCrossRef Streja, D., P. Cressey, and S.W. Rabkin. 2003. Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus. Journal of Diabetes and its Complications 17(3): 120–127.PubMedCrossRef
27.
go back to reference Trayhurn, P., and I.S. Wood. 2004. Adipokines: Inflammation and the pleiotropic role of white adipose tissue. British Journal of Nutrition 92(3): 347–355.PubMedCrossRef Trayhurn, P., and I.S. Wood. 2004. Adipokines: Inflammation and the pleiotropic role of white adipose tissue. British Journal of Nutrition 92(3): 347–355.PubMedCrossRef
28.
go back to reference Weisberg, S.P., D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W. Ferrante Jr. 2003. Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 112(12): 1796–1808.PubMedCentralPubMedCrossRef Weisberg, S.P., D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W. Ferrante Jr. 2003. Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 112(12): 1796–1808.PubMedCentralPubMedCrossRef
29.
go back to reference Sam, S., S. Haffner, M.H. Davidson, et al. 2009. Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes. Diabetes Care 32(5): 932–937.PubMedCentralPubMedCrossRef Sam, S., S. Haffner, M.H. Davidson, et al. 2009. Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes. Diabetes Care 32(5): 932–937.PubMedCentralPubMedCrossRef
30.
go back to reference Miao, C.Y., and Z.Y. Li. 2012. The role of perivascular adipose tissue in vascular smooth muscle cell growth. British Journal of Pharmacology 165(3): 643–658.PubMedCentralPubMedCrossRef Miao, C.Y., and Z.Y. Li. 2012. The role of perivascular adipose tissue in vascular smooth muscle cell growth. British Journal of Pharmacology 165(3): 643–658.PubMedCentralPubMedCrossRef
31.
go back to reference Mojiminiyi, O.A., N. Abdella, M.A. Moussa, A.O. Akanji, H. Mohammedi, and M. Zaki. 2002. Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 58(1): 37–44.PubMedCrossRef Mojiminiyi, O.A., N. Abdella, M.A. Moussa, A.O. Akanji, H. Mohammedi, and M. Zaki. 2002. Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 58(1): 37–44.PubMedCrossRef
32.
go back to reference Prasad, K. 2006. C-reactive protein (CRP)-lowering agents. Cardiovascular Drug Reviews 24(1): 33–50.PubMedCrossRef Prasad, K. 2006. C-reactive protein (CRP)-lowering agents. Cardiovascular Drug Reviews 24(1): 33–50.PubMedCrossRef
33.
go back to reference Palmas, W., S. Ma, B. Psaty, D.C. Goff Jr., C. Darwin, and R.G. Barr. 2007. Antihypertensive medications and C-reactive protein in the multi-ethnic study of atherosclerosis. American Journal of Hypertension 20(3): 233–241.PubMedCrossRef Palmas, W., S. Ma, B. Psaty, D.C. Goff Jr., C. Darwin, and R.G. Barr. 2007. Antihypertensive medications and C-reactive protein in the multi-ethnic study of atherosclerosis. American Journal of Hypertension 20(3): 233–241.PubMedCrossRef
34.
go back to reference Sathyapalan, T., S.L. Atkin, and E.S. Kilpatrick. 2010. Disparate effects of atorvastatin compared with simvastatin on C-reactive protein concentrations in patients with type 2 diabetes. Diabetes Care 33(9): 1948–1950.PubMedCentralPubMedCrossRef Sathyapalan, T., S.L. Atkin, and E.S. Kilpatrick. 2010. Disparate effects of atorvastatin compared with simvastatin on C-reactive protein concentrations in patients with type 2 diabetes. Diabetes Care 33(9): 1948–1950.PubMedCentralPubMedCrossRef
35.
go back to reference Bahceci, M., A. Tuzcu, C. Ogun, N. Canoruc, K. Iltimur, and C. Aslan. 2005. Is serum CRP concentration correlated with HbA1c and insulin resistance in type 2 diabetic men with or without coronary heart disease? Journal of Endocrinological Investigation 28(2): 145–150.PubMed Bahceci, M., A. Tuzcu, C. Ogun, N. Canoruc, K. Iltimur, and C. Aslan. 2005. Is serum CRP concentration correlated with HbA1c and insulin resistance in type 2 diabetic men with or without coronary heart disease? Journal of Endocrinological Investigation 28(2): 145–150.PubMed
36.
go back to reference King, D.E., A.G. Mainous 3rd, T.A. Buchanan, and W.S. Pearson. 2003. C-reactive protein and glycemic control in adults with diabetes. Diabetes Care 26(5): 1535–1539.PubMedCrossRef King, D.E., A.G. Mainous 3rd, T.A. Buchanan, and W.S. Pearson. 2003. C-reactive protein and glycemic control in adults with diabetes. Diabetes Care 26(5): 1535–1539.PubMedCrossRef
37.
go back to reference Pradhan, A.D., B.M. Everett, N.R. Cook, N. Rifai, and P.M. Ridker. 2009. Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: The LANCET randomized trial. JAMA 302(11): 1186–1194.PubMedCrossRef Pradhan, A.D., B.M. Everett, N.R. Cook, N. Rifai, and P.M. Ridker. 2009. Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: The LANCET randomized trial. JAMA 302(11): 1186–1194.PubMedCrossRef
Metadata
Title
Increased Concentration of C-Reactive Protein in Obese Patients with Type 2 Diabetes Is Associated with Obesity and Presence of Diabetes but Not with Macrovascular and Microvascular Complications or Glycemic Control
Authors
Aneta Fronczyk
Piotr Molęda
Krzysztof Safranow
Wiesław Piechota
Lilianna Majkowska
Publication date
01-04-2014
Publisher
Springer US
Published in
Inflammation / Issue 2/2014
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-013-9746-4

Other articles of this Issue 2/2014

Inflammation 2/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine